首页> Cancer medicine> Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India.

Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India.

导出 LinkOut

翻译打印收藏纠错

第一作者： Tushar,Mungle

第一单位： Clinical Research Unit, Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, India.

作者： Tushar,Mungle ^[1] ; Nandana,Das ^[1] ; Saikat,Pal ^[2] ; Manash Pratim,Gogoi ^[1] ; Parag,Das ^[1] ; Niharendu,Ghara ^[3] ; Debjani,Ghosh ^[3] ; Ramandeep Singh,Arora ^[4] ; Nickhill,Bhakta ^[5] ; Vaskar,Saha ^[6] ; Shekhar,Krishnan ^[6]

作者单位： Clinical Research Unit, Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, India. ^[1] Tata Consultancy Services, Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, India. ^[2] Department of Paediatric Haematology and Oncology, Tata Medical Center, Kolkata, India. ^[3] Department of Medical Oncology, Max Super Speciality Hospital, New Delhi, India. ^[4] Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, Tennessee, USA. ^[5] Clinical Research Unit, Tata Translational Cancer Research Centre, Tata Medical Center, Kolkata, India.;Department of Paediatric Haematology and Oncology, Tata Medical Center, Kolkata, India.;Division of Cancer Sciences, Faculty of Biology, Medicine and Health, School of Medical Sciences, University of Manchester, Manchester, UK. ^[6]

关键词 cost-effectiveness low-middle income countries pediatric acute lymphoblastic leukemia risk-stratified therapy treatment cost

医学主题词儿童(Child);人类(Humans);回顾性研究(Retrospective Studies);前体T细胞淋巴母细胞白血病淋巴瘤(Precursor T-Cell Lymphoblastic Leukemia-Lymphoma);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卫生保健费用(Health Care Costs)

DOI 10.1002/cam4.5140

PMID 36812120

发布时间 2024-09-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交